Multiple Sclerosis (MS) Support Group
This community is a place where members can discuss current events and weigh in on what's going on in the world.
You can't be already on LDN to participate.
~~~~~~~~~~~~~~~~~~~~~~~~~
This study is currently recruiting participants.
Verified by University of California, San Francisco
This is a randomized placebo-controlled, parallel-group study, crossover-design of the effects of low dose naltrexone on the multiple sclerosis quality of life inventory (MSQLI54)
This study will assess the impact of LDN compared to placebo on quality of life as measured by the composite score of the MSQOL54 in adult subjects with MS.
Also we plan:
To compare the 10 scales of the MSQOL54 during the active treatment and placebo cycles between active treatment and placebo groups
To compare each individual?s composite response to LDN versus placebo during the active treatment and placebo cycles
To compare each individual on the 10 scales of the MSQOL54 during the active treatment and placebo cycles
Primary Outcome Measures:
comparison of the mean score between treated and placebo groups, adjusting for differences in the baseline score between the two groups; comparison of each of the 10 scales of the MSQLI54 between treated and placebo groups [ Time Frame: 17 weeks ]
Enrollment: 80
Start Date: February 2007
Expected Completion Date:
December 2007
For more information:
http://clinicaltrials.gov/ct2/show/NCT00501696?term=low+dose+naltrexone&rank=2&show_desc=Y#desc
~~~~~~~~~~~~~~~~~~~~~~~~~
This study is currently recruiting participants.
Verified by University of California, San Francisco
This is a randomized placebo-controlled, parallel-group study, crossover-design of the effects of low dose naltrexone on the multiple sclerosis quality of life inventory (MSQLI54)
This study will assess the impact of LDN compared to placebo on quality of life as measured by the composite score of the MSQOL54 in adult subjects with MS.
Also we plan:
To compare the 10 scales of the MSQOL54 during the active treatment and placebo cycles between active treatment and placebo groups
To compare each individual?s composite response to LDN versus placebo during the active treatment and placebo cycles
To compare each individual on the 10 scales of the MSQOL54 during the active treatment and placebo cycles
Primary Outcome Measures:
comparison of the mean score between treated and placebo groups, adjusting for differences in the baseline score between the two groups; comparison of each of the 10 scales of the MSQLI54 between treated and placebo groups [ Time Frame: 17 weeks ]
Enrollment: 80
Start Date: February 2007
Expected Completion Date:
December 2007
For more information:
http://clinicaltrials.gov/ct2/show/NCT00501696?term=low+dose+naltrexone&rank=2&show_desc=Y#desc
-
theatre and I are there already. I'm having a very berry tea with crackers, cheese and cherry tomatoes and she's having a joint with some beer and we're both on really comfy recliners on thick pile carpet. we need some help with the decor if anyone is around??
-
I'm trying to exercise daily. I was doing fairly well until I sprained my ankle 2 weeks ago but now I'm getting back on the horse. Today I walked over a mile with my arm weights that are about 22lbs total. I was out of shape and it was hard on my arms. I also did my 30 situps. I'm also going to drink a lot of water and try to eat healthy. I do tend to have a sweet tooth but I'm cutting...
This is underway and due to end next month.
In Phase III trials, the experimental study drug or treatment is given to large groups of peple (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the experimental drug or treatment to be used safely.
In Phase IV trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
The study at UCSF is finished, I spoke with Elena, she is working with Dr. Cree, they are gathering all the data, the results probably won't be out until sometime in Dec. or Jan.
Vick from Calif